Does RANOLAZINE Cause Electrocardiogram qt prolonged? 98 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 98 reports of Electrocardiogram qt prolonged have been filed in association with RANOLAZINE (Ranolazine). This represents 1.0% of all adverse event reports for RANOLAZINE.
98
Reports of Electrocardiogram qt prolonged with RANOLAZINE
1.0%
of all RANOLAZINE reports
18
Deaths
51
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From RANOLAZINE?
Of the 98 reports, 18 (18.4%) resulted in death, 51 (52.0%) required hospitalization, and 12 (12.2%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANOLAZINE. However, 98 reports have been filed with the FAERS database.
What Other Side Effects Does RANOLAZINE Cause?
Death (692)
Myocardial infarction (610)
Stent placement (593)
Chest pain (592)
Angina pectoris (583)
Dizziness (517)
Dyspnoea (348)
Cerebrovascular accident (334)
Fall (299)
Off label use (270)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which RANOLAZINE Alternatives Have Lower Electrocardiogram qt prolonged Risk?
RANOLAZINE vs RAPAMUNE
RANOLAZINE vs RASAGILINE
RANOLAZINE vs RASBURICASE
RANOLAZINE vs RAVULIZUMAB
RANOLAZINE vs RAVULIZUMAB-CWVZ